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fraction, diabetes, or peripheral vascular disease.
In a nationwide cohort of 9,047 patients in Sweden
who underwent isolated SAVR over a 15-year period,
we found that a small increase in post-operative serum
creatinine of only $0.3 mg/dl ($26 mmol/l) was asso-
ciated with a 27% increased risk of death and a >4-fold
increased risk of ESRD during follow-up. The
increased risk of death or ESRD in patients with AKI
was independent of pre-operative renal function and
other clinically relevant parameters. The main
strength of our study was the nationwide population-
based design with complete and accurate follow-up,
ensuring a high external validity. The main limita-
tions were that few patients developed ESRD during
follow-up, which resulted in low precision in ESRD
risk estimates and the possibility of residual con-
founding. Our ﬁndings are interesting, because very
few patients had established coronary artery disease
and because risk factors for cardiovascular disease
were less prevalent than in previous studies on AKI
after cardiac surgery that included patients who had
coronary artery disease. In the present study, the as-
sociations between AKI and increased risk of ESRD
were similar to the results of our prior study on AKI
after coronary artery bypass graft (CABG) and risk of
ESRD (2). Patients who underwent isolated CABG were
more often diabetic (23% vs. 14%) and more likely to
have had a prior myocardial infarction (45% vs. 8%)
compared with patients in the present study (2).
These ﬁndings strengthen the idea that there
may well be a causal relationship between AKI and
adverse outcomes and that AKI may not merely be a
marker of more advanced atherosclerotic disease.
From a clinical perspective, we believe that our
ﬁndings underscore the need for close monitoring
of patients with AKI. This may be especially
important for patients who undergo isolated SAVR
because they are less likely to receive medication
that can prevent deterioration of renal function
compared with CABG patients, who often already
have guideline-recommended secondary prevention
medication.Linda C. Rydén, MD, PhD
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BMI Reduction Decreases
AF Recurrence Rate in a
Mediterranean CohortThe interesting reading of the excellent articles by
Pathak et al. (1,2) triggered us to retrospectively re-
view a cohort of 1,068 consecutive patients with
atrial ﬁbrillation (AF), to evaluate whether the cor-
relation between body mass index (BMI) and AF
behavior could also be veriﬁed in an unselected
group of Mediterranean patients, being that, to the
best of our knowledge, such information is still
unreported.
Among 653 patients referred between 2005 and
2014, 258 patients with the following data available
were included: electrocardiographic (ECG) docu-
mentation of paroxysmal or persistent AF, initial
and follow-up BMI data, reliable ability to report
AF-related symptoms, exhaustive clinical history,
guidelines-consistent (3) treatment, and at least
3 reassessments during a minimum 6-months
follow-up period. Exclusion criteria were the same
as in LEGACY (Long-Term Effect of Goal Directed
Weight Management on Atrial Fibrillation Cohort: A
5 Year Follow-Up Study). According to BMI and its
variation during follow-up, patients were stratiﬁed
into 4 groups, as follows: Group 1 (n ¼ 42, baseline
BMI <25 kg/m2 and unchanged during the follow-
up); Group 2 (n ¼ 81, BMI >25 kg/m2 and losing 2 or
more units during the follow-up); Group 3 (n ¼ 73,
with BMI >25 kg/m2, unchanged during the follow-
up); Group 4 (n ¼ 62, BMI >25 kg/m2 and gaining
2 or more units during the follow-up). All were
encouraged to keep/reach BMI #25 kg/m2 with diet
and/or moderate exercise. Overall follow-up was
602 patient-years. ECG-documented AF recurrences
were most frequent in Group 4 patients, with a
signiﬁcant correlation between BMI behavior and
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(every 2.6 months [Group 4], 5.5 months [Group 3],
13.7 months [Group 2], and 15.2 months [Group 1]).
Therefore, we can conﬁrm that BMI reduction has a
preventive effect against AF recurrence and that the
LEGACY study results can be applied also to
Mediterranean patients. In addition, we found that
the clinical outcome of AF can be further improved,
with similar incidence of comorbidities, if the target
BMI reduction is higher (average 5.6 U, in our
population).Francesco Fioravanti, MD
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REPLY: BMI Reduction Decreases AFRecurrence Rate in a Mediterranean CohortWe thank Dr. Fioravanti and colleagues for running
this analysis in the Mediterranean population and
validating the key ﬁndings of LEGACY (Long-Term
Effect of Goal Directed Weight Management on
Atrial Fibrillation Cohort: A 5 Year Follow-Up Study)
(1). This study demonstrated that in overweight
and obese individuals with symptomatic atrial
ﬁbrillation (AF), progressive weight loss had a dose-
dependent effect on long-term freedom from AF.
With weight loss, we saw reduced burden of AF and
improved maintenance of sinus rhythm (1). Cardiacrisk factors are associated with structural and
electrical remodeling leading to development and
progression of AF (2). Epidemiological studies
conﬁrm that the risk is dynamic in nature.
Fioravanti and colleagues, in a large cohort of
patients, looked at the dynamic impact of weight on
AF recurrence. The authors found an increased risk
of AF with BMI >25 kg/m2. This study conﬁrms the
already established relationship between increased
BMI and risk of AF. Additionally, it also testiﬁes to
the distinct effect of change in BMI on AF recur-
rence. Weight loss during follow-up was associated
with reduced risk of AF, and a weight gain by
contrast increased this risk. In addition, there was a
dose-response effect of weight loss on AF recur-
rence. These ﬁndings are consistent with LEGACY
study data.
Recent epidemiological data conﬁrm the emergence
of obesity and AF as global epidemics, conferring an
enormous management and economic burden. The
identiﬁcation of risk factors for AF has ushered a risk
factor–based approach for management. Indeed,
aggressivemanagement of risk factorswithweight loss
and increased physical activity are crucial elements in
the management of AF (3,4).Rajeev K. Pathak, MBBS
Rajiv Mahajan, MD, PhD
Dennis H. Lau, MBBS, PhD
*Prashanthan Sanders, MBBS, PhD
*Centre for Heart Rhythm Disorders
Department of Cardiology
Royal Adelaide Hospital
North Terrace
Adelaide 5000
Australia
E-mail: prash.sanders@adelaide.edu.au
http://dx.doi.org/10.1016/j.jacc.2015.08.885
Please note: Dr. Pathak is supported by a post-graduate scholarship from the
Lion’s Medical Research Foundation, an Australian post-graduate award, and
a Leo J. Mahar Electrophysiology Scholarship from the University of Ade-
laide. Dr. Mahajan is supported by the Leo J. Mahar Lectureship from the
University of Adelaide. Dr. Lau is supported by a Postdoctoral Fellowship
from the National Health and Medical Research Council of Australia and the
Robert J. Craig Lectureship from the University of Adelaide. Dr. Sanders is
supported by practitioner fellowships from the National Health and Medical
Research Council of Australia and by the National Heart Foundation of
Australia; has served on the advisory board of Biosense-Webster, Medtronic,
and St. Jude Medical; has received lecture and/or consulting fees from
Biosense-Webster, Medtronic, and St. Jude Medical; and has received
research funding from Medtronic, St. Jude Medical, Boston Scientiﬁc,
Biotronik, and Sorin.REF ER ENCES
1. Pathak RK, Middeldorp ME, Meredith M, et al. Long-Term Effect
of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: A
Long-Term Follow-Up Study (LEGACY). J Am Coll Cardiol 2015;65:
2159–69.
